A federal grand jury is investigating the practices of Denver-based kidney-dialysis firm DaVita. Chief executive Kent Thiry said Wednesday it appears the Colorado investigation is part of an investigation that began in 2005 by the U.S. Attorney’s Office in Missouri looking into allegations that DaVita overused the anemia drug Epogen and then billed the government […]

This content is only available to members of the CSBJ.

To gain access, you’ll need to sign in or purchase Digital, Print & Digital Plus, Print & Digital, Print, Digital and The Transcript, Corporate Membership or Digital Monthly

If you’re already a member, sign in here.